Company intelligence / Profile preview

Tomorrow

Alameda, California, USAhome.tomorrowhealth.com ↗

Ownership: Private
Employees: ~190
Development stage: Commercial

Overview

Tomorrow Biotech operates as an ecosystem for early-stage life science startups, providing laboratory infrastructure, mentoring, business support services, and access to investors. It has helped over 42 member companies raise more than $900M collectively. The focus areas include therapeutics (~40%), sustainability (~40%), and diagnostics (~20%). The organization does not conduct its own clinical trials but accelerates development for its members through world-class lab facilities and business support.

Modalities: Small molecule therapiesMonoclonal antibodiesDiagnostics platforms
Industry: Investors

Beyond the preview

Go deeper on Tomorrow.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tomorrow.

Explore the full profile